Tadros Ramy's most recent trade in Metlife Inc was a trade of 23,006 Common Stock done . Disclosure was reported to the exchange on Feb. 24, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| MetLife | Ramy Tadros | President, U.S. Business | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2026 | 23,006 | 224,284 (0%) | 0% | - | Common Stock | |
| MetLife | Ramy Tadros | President, U.S. Business | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2026 | 19,910 | 201,278 (0%) | 0% | - | Common Stock | |
| MetLife | Ramy Tadros | President, U.S. Business | Payment of exercise price or tax liability using portion of securities received from the company at price $ 75.34 per share. | 24 Feb 2026 | 2,299 | 221,985 (0%) | 0% | 75.3 | 173,207 | Common Stock |
| MetLife | Ramy Tadros | President, U.S. Business | Payment of exercise price or tax liability using portion of securities received from the company at price $ 85.70 per share. | 03 Mar 2025 | 4,863 | 181,368 (0%) | 0% | 85.7 | 416,759 | Common Stock |
| MetLife | Ramy Tadros | President, U.S. Business | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2025 | 44,959 | 209,276 (0%) | 0% | - | Common Stock | |
| MetLife | Ramy Tadros | President, U.S. Business | Payment of exercise price or tax liability using portion of securities received from the company at price $ 82.20 per share. | 25 Feb 2025 | 23,045 | 186,231 (0%) | 0% | 82.2 | 1,894,299 | Common Stock |
| MetLife | Ramy Tadros | President, U.S. Business | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2025 | 17,336 | 164,317 (0%) | 0% | - | Common Stock | |
| MetLife | Ramy Tadros | President, U.S. Business | Sale of securities on an exchange or to another person at price $ 71.90 per share. | 13 Mar 2024 | 4,026 | 146,981 (0%) | 0% | 71.9 | 289,479 | Common Stock |
| MetLife | Ramy Tadros | President, U.S. Business | Payment of exercise price or tax liability using portion of securities received from the company at price $ 69.73 per share. | 01 Mar 2024 | 4,821 | 151,007 (0%) | 0% | 69.7 | 336,168 | Common Stock |
| MetLife | Ramy Tadros | President, U.S. Business | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2024 | 62,924 | 188,464 (0%) | 0% | - | Common Stock | |
| MetLife | Tadros Ramy | President, U.S. Business | Payment of exercise price or tax liability using portion of securities received from the company at price $ 69.16 per share. | 27 Feb 2024 | 32,636 | 155,828 (0%) | 0% | 69.2 | 2,257,106 | Common Stock |
| MetLife | Tadros Ramy | President, U.S. Business | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2024 | 28,113 | 28,113 | - | - | Employee Stock Options (right to buy) | |
| MetLife | Tadros Ramy | President, U.S. Business | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2024 | 9,370 | 125,540 (0%) | 0% | - | Common Stock | |
| MetLife | Ramy Tadros | President, U.S. Business | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Aug 2023 | 7,894 | 116,170 (0%) | 0% | - | Common Stock | |
| MetLife | Ramy Tadros | President, U.S. Business | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 68,986 | 149,322 (0%) | 0% | - | Common Stock | |
| MetLife | Ramy Tadros | President, U.S. Business | Payment of exercise price or tax liability using portion of securities received from the company at price $ 71.73 per share. | 28 Feb 2023 | 36,063 | 113,259 (0%) | 0% | 71.7 | 2,586,799 | Common Stock |
| MetLife | Ramy Tadros | President, U.S. Business | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 25,722 | 25,722 | - | - | Employee Stock Options (right to buy) | |
| MetLife | Ramy Tadros | President, U.S. Business | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 8,574 | 80,336 (0%) | 0% | - | Common Stock | |
| MetLife | Ramy Tadros | President, U.S. Business | Payment of exercise price or tax liability using portion of securities received from the company at price $ 71.27 per share. | 28 Feb 2023 | 4,983 | 108,276 (0%) | 0% | 71.3 | 355,138 | Common Stock |
| MetLife | Ramy Tadros | President, U.S. Business | Payment of exercise price or tax liability using portion of securities received from the company at price $ 64.44 per share. | 01 Mar 2022 | 4,668 | 71,762 (0%) | 0% | 64.4 | 300,806 | Common Stock |
| MetLife | Ramy Tadros | President, U.S. Business | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2022 | 44,304 | 98,752 (0%) | 0% | - | Common Stock | |
| MetLife | Ramy Tadros | President, U.S. Business | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2022 | 25,283 | 25,283 | - | - | Employee Stock Options (right to buy) | |
| MetLife | Ramy Tadros | President, U.S. Business | Payment of exercise price or tax liability using portion of securities received from the company at price $ 68.96 per share. | 22 Feb 2022 | 22,322 | 76,430 (0%) | 0% | 69.0 | 1,539,325 | Common Stock |
| MetLife | Ramy Tadros | President, U.S. Business | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2022 | 8,429 | 54,448 (0%) | 0% | - | Common Stock |